Efficacy and safety of long-acting rispe
โ
Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariรซlle Eerd
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 93 KB
๐ 2 views
## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Longโacting risperidone, the first longโacting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi